Neogen Corp (NEOG)
15.78
+0.32
(+2.07%)
USD |
NASDAQ |
Mar 28, 16:00
15.77
-0.01
(-0.06%)
After-Hours: 20:00
Neogen Revenue (TTM): 918.68M for Nov. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
November 30, 2023 | 918.68M |
August 31, 2023 | 919.08M |
May 31, 2023 | 822.45M |
February 28, 2023 | 720.73M |
November 30, 2022 | 630.72M |
August 31, 2022 | 531.20M |
May 31, 2022 | 527.16M |
February 28, 2022 | 514.49M |
November 30, 2021 | 502.96M |
August 31, 2021 | 487.44M |
May 31, 2021 | 468.46M |
February 28, 2021 | 450.11M |
November 30, 2020 | 433.27M |
August 31, 2020 | 426.07M |
May 31, 2020 | 418.17M |
February 29, 2020 | 418.86M |
November 30, 2019 | 416.69M |
August 31, 2019 | 415.98M |
May 31, 2019 | 414.19M |
February 28, 2019 | 412.54M |
November 30, 2018 | 409.75M |
August 31, 2018 | 403.35M |
May 31, 2018 | 397.93M |
February 28, 2018 | 385.34M |
November 30, 2017 | 378.82M |
Date | Value |
---|---|
August 31, 2017 | 368.84M |
May 31, 2017 | 358.28M |
February 28, 2017 | 352.83M |
November 30, 2016 | 341.17M |
August 31, 2016 | 330.06M |
May 31, 2016 | 321.27M |
February 29, 2016 | 309.81M |
November 30, 2015 | 301.49M |
August 31, 2015 | 290.34M |
May 31, 2015 | 283.07M |
February 28, 2015 | 271.72M |
November 30, 2014 | 265.31M |
August 31, 2014 | 256.46M |
May 31, 2014 | 247.40M |
February 28, 2014 | 236.15M |
November 30, 2013 | 225.21M |
August 31, 2013 | 216.35M |
May 31, 2013 | 207.53M |
February 28, 2013 | 200.07M |
November 30, 2012 | 193.92M |
August 31, 2012 | 188.08M |
May 31, 2012 | 184.04M |
February 29, 2012 | 179.10M |
November 30, 2011 | 176.42M |
August 31, 2011 | 175.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
414.19M
Minimum
May 2019
919.08M
Maximum
Aug 2023
549.30M
Average
487.44M
Median
Aug 2021
Revenue (TTM) Benchmarks
Haemonetics Corp | 1.270B |
Cutera Inc | 230.18M |
Cyclacel Pharmaceuticals Inc | -- |
ClearPoint Neuro Inc | 23.96M |
Elicio Therapeutics Inc | -- |